The journal
Open the journal →The conversation starts in the journal — be the first to post.
About John C. Martin
John Charles Martin (May 7, 1951 – March 30, 2021) was an American billionaire businessman, and the former executive chairman (2016–2018) and CEO (1996–2016) of the American biotechnology company Gilead Sciences. He joined Gilead Sciences in 1990 as vice president for research and development. Gilead is known for developing drugs such as Atripla (for HIV/AIDS) and commercializing Sovaldi (sofosbuvir) for the treatment of the liver virus hepatitis C. Martin is the recipient of a number of awards, including the Biotechnology Heritage Award (2017).
Everything about John C. Martin →- Occupation
- chief executive officer, entrepreneur, chemist
- Position held
- chairperson
- Citizenship
- United States
- Born
- 1951, May 7, 1951
- Died
- March 30, 2021